Not Yet RecruitingNot applicableNCT07461662

Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination

Endobronchial ultrasound (EBUS) bronchoscopy is commonly used to sample lymph nodes in patients with suspected or known lung cancer to determine the stage of the disease. Accurate staging is essential as it directly impacts treatment decisions and prognosis. During EBUS procedures, needles are often reused across multiple lymph node stations and are typically flushed with saline between samples. This raises the concern that residual tumor cells may contaminate the samples and could potentially incorrectly upstage disease. This prospective study will evaluate the current technique used during EBUS procedures to determine if more intensive cleaning leads to reduced cellular contamination without affecting diagnostics. Patients undergoing an EBUS procedure for diagnosis with a large mass and a high probability of malignancy will be selected for the study. Rapid On-Site Examination (ROSE) will be used at the bedside to determine the presence of abnormal cells. Following the final pass, before moving to the next station, the needle will be flushed with saline as normal and then flushed again into another container to evaluate the presence of residual cells. The outcome may help EBUS needle handling practices and improve lung cancer staging accuracy. No additional invasive procedures are performed as part of this study; all analyses utilize material obtained during routine EBUS needle flushing, with no added needle sticks or alteration of clinical care.

Checked against the public recordLast updated Mar 10, 2026 · Source: ClinicalTrials.gov

StatusNot Yet Recruiting
PhaseNot applicable
U.S. locations1
SponsorUniversity of Mississippi Medical Center
01
Study overview

What this study is about

Purpose
Diagnostic
Study type
Interventional
Phase
Not applicable
Sponsor
University of Mississippi Medical Center
Interventions being studied
Diagnostic Test: Purge cleaning
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Adults aged 18 years or older * Patients undergoing standard-of-care EBUS bronchoscopy for evaluation of suspected lung malignancy * Patients undergoing sampling of 2 or more lymph node stations during EBUS bronchoscopy * Ability to provide informed consent Exclusion Criteria: * Age less than 18 * Recent (1 month or less) radiation or procedural manipulation of lymph node stations that may significantly change lymph node architecture

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Mississippi Medical CenterJackson, Mississippi

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 10, 2026. Always confirm current availability with the study team.

View original record ↗